APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phentolamine Mesylate Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Phentolamine Mesylate Injection Industry Growth and Trends Forecast to 2032

28 December 202597 pages

Choose your research edition.

Industry ResearchPhentolamine Mesylate Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Phentolamine Mesylate Injection Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Phentolamine Mesylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phentolamine Mesylate Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Phentolamine Mesylate Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Phentolamine Mesylate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phentolamine Mesylate Injection include Hikma, Precision Dose, Septodont, Hainan Poly Pharm, CR Double-Crane, Sunflower Pharmaceutical, Shanghai Fudan Forward Pharmaceuticals and Sichuan Meida Kangjiale Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Phentolamine Mesylate Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Phentolamine Mesylate Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Phentolamine Mesylate Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Phentolamine Mesylate Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Phentolamine Mesylate Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Phentolamine Mesylate Injection Market by Company

Hikma

Precision Dose

Septodont

Hainan Poly Pharm

CR Double-Crane

Sunflower Pharmaceutical

Shanghai Fudan Forward Pharmaceuticals

Sichuan Meida Kangjiale Pharmaceutical

Phentolamine Mesylate Injection Segment by Type

Intravenous Injection

Intramuscular Injection

Phentolamine Mesylate Injection Segment by Application

Hospital and Clinic

Pharmacy

Other

Phentolamine Mesylate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phentolamine Mesylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phentolamine Mesylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phentolamine Mesylate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Phentolamine Mesylate Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Phentolamine Mesylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intravenous Injection Table 2. Major Company of Intramuscular Injection Table 3. Global Phentolamine Mesylate Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Phentolamine Mesylate Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Phentolamine Mesylate Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Phentolamine Mesylate Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Phentolamine Mesylate Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Phentolamine Mesylate Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Phentolamine Mesylate Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Phentolamine Mesylate Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Phentolamine Mesylate Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Phentolamine Mesylate Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Phentolamine Mesylate Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Phentolamine Mesylate Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Phentolamine Mesylate Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Phentolamine Mesylate Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Phentolamine Mesylate Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Phentolamine Mesylate Injection Industry Trends Table 25. Phentolamine Mesylate Injection Industry Drivers Table 26. Phentolamine Mesylate Injection Industry Opportunities and Challenges Table 27. Phentolamine Mesylate Injection Industry Restraints Table 28. Global Phentolamine Mesylate Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Phentolamine Mesylate Injection Revenue Market Share by Company (2021-2026) Table 30. Global Phentolamine Mesylate Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Phentolamine Mesylate Injection Sales Share by Company (2021-2026) Table 32. Global Phentolamine Mesylate Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Phentolamine Mesylate Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Phentolamine Mesylate Injection Major Company Production Sites and Headquarters Table 35. Global Phentolamine Mesylate Injection Company, Product Type & Application Table 36. Global Phentolamine Mesylate Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Phentolamine Mesylate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Phentolamine Mesylate Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Phentolamine Mesylate Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Phentolamine Mesylate Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Phentolamine Mesylate Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Phentolamine Mesylate Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Phentolamine Mesylate Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Phentolamine Mesylate Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Phentolamine Mesylate Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Phentolamine Mesylate Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Phentolamine Mesylate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Phentolamine Mesylate Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Phentolamine Mesylate Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Phentolamine Mesylate Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Phentolamine Mesylate Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Phentolamine Mesylate Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Phentolamine Mesylate Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Phentolamine Mesylate Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Phentolamine Mesylate Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Phentolamine Mesylate Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Phentolamine Mesylate Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Phentolamine Mesylate Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Phentolamine Mesylate Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Phentolamine Mesylate Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Phentolamine Mesylate Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Phentolamine Mesylate Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Hikma Company Information Table 72. Hikma Business Overview Table 73. Hikma Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Hikma Phentolamine Mesylate Injection Product Portfolio Table 75. Hikma Recent Development Table 76. Precision Dose Company Information Table 77. Precision Dose Business Overview Table 78. Precision Dose Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Precision Dose Phentolamine Mesylate Injection Product Portfolio Table 80. Precision Dose Recent Development Table 81. Septodont Company Information Table 82. Septodont Business Overview Table 83. Septodont Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Septodont Phentolamine Mesylate Injection Product Portfolio Table 85. Septodont Recent Development Table 86. Hainan Poly Pharm Company Information Table 87. Hainan Poly Pharm Business Overview Table 88. Hainan Poly Pharm Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolio Table 90. Hainan Poly Pharm Recent Development Table 91. CR Double-Crane Company Information Table 92. CR Double-Crane Business Overview Table 93. CR Double-Crane Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. CR Double-Crane Phentolamine Mesylate Injection Product Portfolio Table 95. CR Double-Crane Recent Development Table 96. Sunflower Pharmaceutical Company Information Table 97. Sunflower Pharmaceutical Business Overview Table 98. Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolio Table 100. Sunflower Pharmaceutical Recent Development Table 101. Shanghai Fudan Forward Pharmaceuticals Company Information Table 102. Shanghai Fudan Forward Pharmaceuticals Business Overview Table 103. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolio Table 105. Shanghai Fudan Forward Pharmaceuticals Recent Development Table 106. Sichuan Meida Kangjiale Pharmaceutical Company Information Table 107. Sichuan Meida Kangjiale Pharmaceutical Business Overview Table 108. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolio Table 110. Sichuan Meida Kangjiale Pharmaceutical Recent Development Table 111. North America Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 113. North America Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026) Table 114. North America Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Phentolamine Mesylate Injection Sales Market Share Forecast by Country (2027-2032) Table 116. North America Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Phentolamine Mesylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Phentolamine Mesylate Injection Market Share by Country (2021-2026) Table 119. North America Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Phentolamine Mesylate Injection Market Share Forecast by Country (2027-2032) Table 121. Europe Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 123. Europe Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026) Table 124. Europe Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Phentolamine Mesylate Injection Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Phentolamine Mesylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Phentolamine Mesylate Injection Market Share by Country (2021-2026) Table 129. Europe Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Phentolamine Mesylate Injection Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Phentolamine Mesylate Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Phentolamine Mesylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Phentolamine Mesylate Injection Market Share by Country (2021-2026) Table 139. Asia-Pacific Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Phentolamine Mesylate Injection Market Share Forecast by Country (2027-2032) Table 141. Latin America Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 143. Latin America Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026) Table 144. Latin America Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Phentolamine Mesylate Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Phentolamine Mesylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Phentolamine Mesylate Injection Market Share by Country (2021-2026) Table 149. Latin America Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Phentolamine Mesylate Injection Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Phentolamine Mesylate Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Phentolamine Mesylate Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Phentolamine Mesylate Injection Market Share by Country (2021-2026) Table 159. Middle East and Africa Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Phentolamine Mesylate Injection Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Phentolamine Mesylate Injection Distributors List Table 164. Phentolamine Mesylate Injection Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Phentolamine Mesylate Injection Image Figure 2. Global Phentolamine Mesylate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phentolamine Mesylate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Phentolamine Mesylate Injection Sales (2021-2032) & (K Units) Figure 5. Intravenous Injection Image Figure 6. Global Intravenous Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Intramuscular Injection Image Figure 8. Global Intramuscular Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Phentolamine Mesylate Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Phentolamine Mesylate Injection Market Share by Type 2025 VS 2032 Figure 11. North America Phentolamine Mesylate Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Phentolamine Mesylate Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Phentolamine Mesylate Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Phentolamine Mesylate Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Phentolamine Mesylate Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Phentolamine Mesylate Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Phentolamine Mesylate Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Phentolamine Mesylate Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Phentolamine Mesylate Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Phentolamine Mesylate Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Phentolamine Mesylate Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Phentolamine Mesylate Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Phentolamine Mesylate Injection Market Share by Application 2025 VS 2032 Figure 31. North America Phentolamine Mesylate Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Phentolamine Mesylate Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Phentolamine Mesylate Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Phentolamine Mesylate Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Phentolamine Mesylate Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Phentolamine Mesylate Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Phentolamine Mesylate Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Phentolamine Mesylate Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Phentolamine Mesylate Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Phentolamine Mesylate Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Phentolamine Mesylate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Phentolamine Mesylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Phentolamine Mesylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Phentolamine Mesylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Phentolamine Mesylate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Phentolamine Mesylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Phentolamine Mesylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Phentolamine Mesylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Phentolamine Mesylate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Phentolamine Mesylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Phentolamine Mesylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Phentolamine Mesylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Phentolamine Mesylate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Phentolamine Mesylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Phentolamine Mesylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Phentolamine Mesylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Phentolamine Mesylate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Phentolamine Mesylate Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Phentolamine Mesylate Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Phentolamine Mesylate Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Phentolamine Mesylate Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Phentolamine Mesylate Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Injection
  • Intramuscular Injection
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Hikma
  • Precision Dose
  • Septodont
  • Hainan Poly Pharm
  • CR Double-Crane
  • Sunflower Pharmaceutical
  • Shanghai Fudan Forward Pharmaceuticals
  • Sichuan Meida Kangjiale Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phentolamine Mesylate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Phentolamine Mesylate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Phentolamine Mesylate Injection Market by Type
  6. 1.3.1 Intravenous Injection
  7. 1.3.2 Intramuscular Injection
  8. 1.4 Global Phentolamine Mesylate Injection Market Size by Type
  9. 1.4.1 Global Phentolamine Mesylate Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Phentolamine Mesylate Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Phentolamine Mesylate Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Phentolamine Mesylate Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Phentolamine Mesylate Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Phentolamine Mesylate Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Phentolamine Mesylate Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Phentolamine Mesylate Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Phentolamine Mesylate Injection Industry Trends
  2. 2.2 Phentolamine Mesylate Injection Industry Drivers
  3. 2.3 Phentolamine Mesylate Injection Industry Opportunities and Challenges
  4. 2.4 Phentolamine Mesylate Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Phentolamine Mesylate Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Phentolamine Mesylate Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Phentolamine Mesylate Injection Price (2021-2026)
  4. 3.4 Global Phentolamine Mesylate Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Phentolamine Mesylate Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Phentolamine Mesylate Injection Company, Product Type & Application
  7. 3.7 Global Phentolamine Mesylate Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Phentolamine Mesylate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Phentolamine Mesylate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Phentolamine Mesylate Injection Tier 1, Tier 2, and Tier 3
4 Phentolamine Mesylate Injection Regional Status and Outlook
  1. 4.1 Global Phentolamine Mesylate Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Phentolamine Mesylate Injection Historic Market Size by Region
  3. 4.2.1 Global Phentolamine Mesylate Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Phentolamine Mesylate Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Phentolamine Mesylate Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Phentolamine Mesylate Injection Forecasted Market Size by Region
  7. 4.3.1 Global Phentolamine Mesylate Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Phentolamine Mesylate Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Phentolamine Mesylate Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Phentolamine Mesylate Injection by Application
  1. 5.1 Phentolamine Mesylate Injection Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Phentolamine Mesylate Injection Market Size by Application
  6. 5.2.1 Global Phentolamine Mesylate Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Phentolamine Mesylate Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Phentolamine Mesylate Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Phentolamine Mesylate Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Phentolamine Mesylate Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Phentolamine Mesylate Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Phentolamine Mesylate Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Phentolamine Mesylate Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hikma
  2. 6.1.1 Hikma Company Information
  3. 6.1.2 Hikma Business Overview
  4. 6.1.3 Hikma Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hikma Phentolamine Mesylate Injection Product Portfolio
  6. 6.1.5 Hikma Recent Developments
  7. 6.2 Precision Dose
  8. 6.2.1 Precision Dose Company Information
  9. 6.2.2 Precision Dose Business Overview
  10. 6.2.3 Precision Dose Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Precision Dose Phentolamine Mesylate Injection Product Portfolio
  12. 6.2.5 Precision Dose Recent Developments
  13. 6.3 Septodont
  14. 6.3.1 Septodont Company Information
  15. 6.3.2 Septodont Business Overview
  16. 6.3.3 Septodont Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Septodont Phentolamine Mesylate Injection Product Portfolio
  18. 6.3.5 Septodont Recent Developments
  19. 6.4 Hainan Poly Pharm
  20. 6.4.1 Hainan Poly Pharm Company Information
  21. 6.4.2 Hainan Poly Pharm Business Overview
  22. 6.4.3 Hainan Poly Pharm Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolio
  24. 6.4.5 Hainan Poly Pharm Recent Developments
  25. 6.5 CR Double-Crane
  26. 6.5.1 CR Double-Crane Company Information
  27. 6.5.2 CR Double-Crane Business Overview
  28. 6.5.3 CR Double-Crane Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CR Double-Crane Phentolamine Mesylate Injection Product Portfolio
  30. 6.5.5 CR Double-Crane Recent Developments
  31. 6.6 Sunflower Pharmaceutical
  32. 6.6.1 Sunflower Pharmaceutical Company Information
  33. 6.6.2 Sunflower Pharmaceutical Business Overview
  34. 6.6.3 Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolio
  36. 6.6.5 Sunflower Pharmaceutical Recent Developments
  37. 6.7 Shanghai Fudan Forward Pharmaceuticals
  38. 6.7.1 Shanghai Fudan Forward Pharmaceuticals Company Information
  39. 6.7.2 Shanghai Fudan Forward Pharmaceuticals Business Overview
  40. 6.7.3 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolio
  42. 6.7.5 Shanghai Fudan Forward Pharmaceuticals Recent Developments
  43. 6.8 Sichuan Meida Kangjiale Pharmaceutical
  44. 6.8.1 Sichuan Meida Kangjiale Pharmaceutical Company Information
  45. 6.8.2 Sichuan Meida Kangjiale Pharmaceutical Business Overview
  46. 6.8.3 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolio
  48. 6.8.5 Sichuan Meida Kangjiale Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Phentolamine Mesylate Injection Sales by Country
  2. 7.1.1 North America Phentolamine Mesylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Phentolamine Mesylate Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Phentolamine Mesylate Injection Market Size by Country
  6. 7.2.1 North America Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Phentolamine Mesylate Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Phentolamine Mesylate Injection Sales by Country
  2. 8.1.1 Europe Phentolamine Mesylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Phentolamine Mesylate Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Phentolamine Mesylate Injection Market Size by Country
  6. 8.2.1 Europe Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Phentolamine Mesylate Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Phentolamine Mesylate Injection Sales by Country
  2. 9.1.1 Asia-Pacific Phentolamine Mesylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Phentolamine Mesylate Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Phentolamine Mesylate Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Phentolamine Mesylate Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Phentolamine Mesylate Injection Sales by Country
  2. 10.1.1 South America Phentolamine Mesylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Phentolamine Mesylate Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Phentolamine Mesylate Injection Market Size by Country
  6. 10.2.1 South America Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Phentolamine Mesylate Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Phentolamine Mesylate Injection Sales by Country
  2. 11.1.1 Middle East and Africa Phentolamine Mesylate Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Phentolamine Mesylate Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Phentolamine Mesylate Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Phentolamine Mesylate Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Phentolamine Mesylate Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Phentolamine Mesylate Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Phentolamine Mesylate Injection Value Chain Analysis
  2. 12.1.1 Phentolamine Mesylate Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Phentolamine Mesylate Injection Production Mode & Process
  7. 12.2 Phentolamine Mesylate Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Phentolamine Mesylate Injection Distributors
  10. 12.2.3 Phentolamine Mesylate Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst